Prevalence, Characteristics, and Correlates of Fatigue in Indian Breast Cancer Survivors: A Cross-Sectional Study

被引:2
|
作者
Kaur, Navneet [1 ,2 ]
Mahapatra, Puneet Prasan [1 ,2 ]
Chakraborty, Sagar [1 ,2 ]
机构
[1] Univ Delhi, Univ Coll Med Sci, Delhi, India
[2] Univ Delhi, GTB Hosp, Delhi, India
关键词
breast cancer survivors; fatigue; quality of life; survivorship care; RISK-FACTORS; PSYCHOLOGICAL DISTRESS; FUNCTIONAL ASSESSMENT; THERAPY; METAANALYSIS;
D O I
10.1055/s-0042-1749319
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Fatigue is one of the commonest sequelae of breast cancer treatment that adversely impacts quality of life (QOL) of breast cancer survivors (BCSs). However, very limited data are available about cancer-related fatigue in Indian patients. Hence, this study was planned with the objectives to study (1) prevalence of fatigue in short-, intermediate-, and long-term follow-up; (2) severity and characteristics of fatigue; (3) impact of fatigue on QOL; and (4) correlation of fatigue with other survivorship issues. Materials and Methods The study was conducted on (n = 230) BCSs who had completed their primary treatment (surgery, radiotherapy, and chemotherapy) and were coming for follow-up. The prevalence of fatigue was noted from a screening tool, which comprised of 14 commonly reported survivorship issues. Assessment of fatigue was done by using survivorship fatigue assessment tool-1 score and QOL was assessed by functional assessment of cancer therapy-breast (FACT-B) questionnaires. To understand how fatigue evolved over time, survivors were divided into three groups according to the time elapsed since initial treatment: Group 1: <2 years (n = 105); Group 2: 2-5 years (n = 70); Group 3: >5 years (n = 55). Statistical Analysis Data was analyzed by using simple descriptive statistics, one way analysis of variance followed by Tukey's test for comparison of quantitative data among the three groups, and Pearson correlation coefficients for association of fatigue with other survivorship issues. Results Clinically significant fatigue (>= 4) was noted in 38% of BCSs. However, high overall prevalence of fatigue (60%) was seen, which persisted in long-term survivors (51%) as well. Severity of fatigue was mostly mild (37.7%) tomoderate (47.1%). Fatigue scores were significantly higher in short- term survivors (5.01 +/- 2.06) than intermediate- (4.03 +/- 1.42) and long-term BCSs (3.57 +/- 1.37). The mean score on FACT-B was 90.07 +/- 10.17 in survivors with fatigue and 104.73 +/- 7.13 in those without fatigue (p = 0.000). Significant correlation of fatigue was seen with other survivorship issues like limb swelling, chronic pain, premature menopause, and its related symptoms and emotional distress. Conclusion Fatigue is highly prevalent in BCSs. Survivorship care programs should include appropriate measures to evaluate and address fatigue.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 50 条
  • [1] The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study
    'Ben' Smith, Allan
    King, Madeleine
    Butow, Phyllis
    Luckett, Tim
    Grimison, Peter
    Toner, Guy C.
    Stockler, Martin
    Hovey, Elizabeth
    Stubbs, John
    Hruby, George
    Gurney, Howard
    Turner, Sandra
    Alam, Mahmood
    Cox, Keith
    Olver, Ian
    PSYCHO-ONCOLOGY, 2013, 22 (11) : 2557 - 2564
  • [2] Chronic pain in female breast cancer survivors - prevalence, characteristics and contributing factors: a cross-sectional pilot study
    Shabangu, Nelisiwe
    Thebe, Tselane
    Casey, Michelle
    Wesselmann, Ursula
    Parker, Romy
    BMC WOMENS HEALTH, 2023, 23 (01)
  • [3] Chronic pain in female breast cancer survivors - prevalence, characteristics and contributing factors: a cross-sectional pilot study
    Nelisiwe Shabangu
    Tselane Thebe
    Michelle Casey
    Ursula Wesselmann
    Romy Parker
    BMC Women's Health, 23
  • [4] Fatigue among Long-Term Breast Cancer Survivors: A Controlled Cross-Sectional Study
    Maass, Saskia W. M. C.
    Brandenbarg, Daan
    Boerman, Liselotte M.
    Verhaak, Peter F. M.
    de Bock, Geertruida H.
    Berendsen, Annette J.
    CANCERS, 2021, 13 (06) : 1 - 11
  • [5] Fatigue among long-term breast cancer survivors: a controlled cross-sectional study
    Maass, S.
    Brandenbarg, D.
    Boerman, L.
    Verhaak, P.
    de Bock, G.
    Berendsen, A.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S1 - S2
  • [6] Prevalence and correlates of cancer-related fatigue in breast cancer survivors
    Alvarez-Bustos, Alejandro
    de Pedro, Cristina G.
    Romero-Elias, Maria
    Ramos, Javier
    Osorio, Pablo
    Cantos, Blanca
    Maximiano, Constanza
    Mendez, Miriam
    Fiuza-Luces, Carmen
    Mendez-Otero, Marta
    Martin, Silvia
    Cebolla, Hector
    Ruiz-Casado, Ana
    SUPPORTIVE CARE IN CANCER, 2021, 29 (11) : 6523 - 6534
  • [7] Prevalence and correlates of cancer-related fatigue in breast cancer survivors
    Alejandro Álvarez-Bustos
    Cristina G. de Pedro
    María Romero-Elías
    Javier Ramos
    Pablo Osorio
    Blanca Cantos
    Constanza Maximiano
    Miriam Méndez
    Carmen Fiuza-Luces
    Marta Méndez-Otero
    Silvia Martín
    Héctor Cebolla
    Ana Ruiz-Casado
    Supportive Care in Cancer, 2021, 29 : 6523 - 6534
  • [8] Prevalence and correlates of fatigue and depression in breast cancer survivors: Breast cancer quality care study.
    Kim, S. H.
    Park, B. W.
    Ahn, S. H.
    Noh, D. Y.
    Nam, S. J.
    Lee, E. S.
    Yun, Y. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 48S - 48S
  • [9] A cross-sectional study on cognitive impairment in Mexican breast cancer survivors
    Platas, A.
    Aguila, C.
    Ortega-Leonard, L. V.
    Marquez-Perez, C. J.
    Maradiaga, D. G.
    Burgos-Gonzalez, A.
    Martinez-Cannon, B. A.
    Bargallo-Rocha, E.
    Mohar, A.
    Villarreal-Garza, C. M.
    BREAST, 2016, 29 : S29 - S29
  • [10] Fatigue in Cancer Survivors - Prevalence and Correlates
    Kuhnt, Susanne
    Ernst, Jochen
    Singer, Susanne
    Rueffer, Jens Ulrich
    Kortmann, Rolf-Dieter
    Stolzenburg, Jens-Uwe
    Schwarz, Reinhold
    ONKOLOGIE, 2009, 32 (06): : 312 - 317